Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Jan H. M. Schellens
Based on 44 articles published since 2009
(Why 44 articles?)
||||
Expertise Level
The expertise of Jan H. M. Schellens ranks in the
  • Top 0.24%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 44 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Schellens, J H M   ·   Schellens, J   ·   Schellens, Jan   ·   Schellens, Jan H M   ·   Schellens, Jan H
Work Locations
Details
Most likely:    Leeuwenhoek Hospital      
2018
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 29063517
  • Medical Oncology Department, Vall d'Hebrón University Hospital, Barcelona, Spain. · INCLIVA Biomedical Research Institute, Valencia, Spain. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Instituto Valenciano de Oncología, Valencia, Spain. · Medical University of South Carolina, Charleston, SC, USA. · Texas Oncology, Dallas, TX, USA. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · West German Cancer Center, University Hospital Essen, Essen, Germany. · Thomas Jefferson University, Philadelphia, PA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Manchester University, Manchester, UK. · Greenville Memorial Hospital, Greenville, SC, USA. · Novartis Pharma AG, Basel, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29882016
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg, 6, 1066, EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmaco-epidemiology & Clinical Pharmacology, Utrecht University, P.O. Box 80082, 3508, TB, Utrecht, The Netherlands. · Pubmed 29451684
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · TESARO, Inc., Waltham, MA, USA. · Xceleron, Inc., A Pharmaron Company, Germantown, MD, USA. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 29043410
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 30006796
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. · Division of Pharmacoepidemiology & Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 29429038
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. · Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28762135
2017
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital / The Netherlands Cancer Institute and MC Slotervaart, P.O. Box 90440, 1006 BK, Amsterdam, The Netherlands. · Tesaro Inc., Waltham, MA, USA. · Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital / The Netherlands Cancer Institute and MC Slotervaart, P.O. Box 90440, 1006 BK, Amsterdam, The Netherlands. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 28303528
2016
  • Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Clinical Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584CG, Utrecht, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27323902
  • Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Internal Medicine, Isala Clinics, Zwolle, the Netherlands. · Department of Internal Medicine, Antonius Hospital, Nieuwegein, the Netherlands. · Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands. · Department of Internal Medicine, Wilhelmina Hospital, Assen, the Netherlands. · Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, the Netherlands. · Department of Internal Medicine, Canisius Wilhemina Hospital, Nijmegen, the Netherlands. · Department of Internal Medicine, VieCuri Medical Center Noord-Limburg, Venlo, the Netherlands. · Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands. · Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands. · Department of Internal Medicine, Hospital de Tjongerschans, Heerenveen, the Netherlands. · Department of Cardiology, University Medical Center Groningen, the Netherlands. · Department of Laboratory Medicine University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands18Department of Pharmaceutical Sciences, Science Faculty Utrecht University, Utrecht, the Netherlands. · Pubmed 27348762
  • Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek/Slotervaart Hospital, Louwesweg 6, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek/Slotervaart Hospital, Louwesweg 6, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 26603889
2015
  • Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. Electronic address: · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Louwesweg 6, 1066EC Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, The Netherlands; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Louwesweg 6, 1066EC Amsterdam, The Netherlands. · Pubmed 26547132
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. Electronic address: · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 25997856
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Internal Medicine, Medisch Spectrum Twente, P.O. Box 50 000, 7500 KA, Enschede, The Netherlands. · Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences (UIPS), David de Wied building Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences (UIPS), David de Wied building Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Pubmed 26362459
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · 1] Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · 1] Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands. · Pubmed 26180927
  • Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Pubmed 26283654
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Programa de Farmacologia, Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · University of Helsinki, Helsinki, Finland. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Breakthrough Breast Cancer Centre, London, UK. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. · University of Helsinki, Helsinki, Finland. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. · Department of Pathology, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. · Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Jyväskylä Central Hospital, Jyväskylä, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Australia. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Cancer Epidemiology, Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Breakthrough Breast Cancer Centre, London, UK. · Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Pubmed 26137966
2014
  • Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 24219005
2018
  • Dejan Juric, Massachusetts General Hospital Cancer Center, Boston · Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · Jordi Rodon and Josep Tabernero, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona · Marta Gil-Martin, Catalan Institute of Oncology - Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain · Filip Janku, The University of Texas MD Anderson Cancer Center, Houston, TX · Howard A. Burris, Sarah Cannon Research Institute and Tennessee Oncology · Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN · Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam, the Netherlands · Mark R. Middleton, National Institute for Health Research, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom · Martin Schuler, West German Cancer Center, University Duisburg-Essen, and German Cancer Consortium, Partner Site University Hospital Essen, Essen · Ruth Seggewiss-Bernhardt, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Douglas Bootle, David Demanse, Lars Blumenstein, and Cornelia Quadt, Novartis Pharma AG, Basel, Switzerland · Christina Coughlin, Novartis Pharmaceuticals Corporation, East Hanover, NJ · and José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 29401002
2017
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek and MC Slotervaart, Amsterdam; †Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; and ‡Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands. · Pubmed 28045782
2015
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam †Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam ‡Department of Pathology, University Medical Center Utrecht, Utrecht §Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam ¶Faculty of Science, Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. · Pubmed 26035041
2014
  • European Medicines Agency, London, United Kingdom; Danish Health and Medicines Authority, København, Denmark; Department of Physiology and Pharmacology, Università di Roma "La Sapienza," Rome, Italy; Agenzia Italiana del Farmaco, Rome, Italy; Läkemedelsverket, Medical Products Agency, Uppsala, Sweden; Karolinska Institutet, Stockholm, Sweden; The Netherlands Cancer Institute, Amsterdam, The Netherlands · European Medicines Agency, London, United Kingdom; Danish Health and Medicines Authority, København, Denmark; Department of Physiology and Pharmacology, Università di Roma "La Sapienza," Rome, Italy; Agenzia Italiana del Farmaco, Rome, Italy; Läkemedelsverket, Medical Products Agency, Uppsala, Sweden; Karolinska Institutet, Stockholm, Sweden; The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 24928613
  • Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands, · Pubmed 24859000
  • Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands, · Pubmed 24390246
2013
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23053259
  • Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. · Pubmed 24373320
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 23645005
  • The Netherlands Cancer Institute, Division of Experimental Therapy, Amsterdam, The Netherlands. · Pubmed 23541706
2012
  • The Netherlands Cancer Institute, Department of Clinical Pharmacology, Postbus 90203, 1006 BE Amsterdam, The Netherlands. · Pubmed 22477724
  • Department of Clinical Pharmacology and Experimental Therapy, The Netherlands. · Pubmed 22264977
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22907417
2011
  • Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Pubmed 21392921
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Slotervaart Hospital, Amsterdam, The Netherlands. · Pubmed 21913038
  • The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Division of Clinical Pharmacology, Amsterdam, The Netherlands. · Pubmed 21911720
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 21633346
  • Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 21632460
  • Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21587256
2010
  • Department of Pharmacy & Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. · Pubmed 21094378
Probable:    Universiteit Utrecht      
2018
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 29063517
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg, 6, 1066, EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmaco-epidemiology & Clinical Pharmacology, Utrecht University, P.O. Box 80082, 3508, TB, Utrecht, The Netherlands. · Pubmed 29451684
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · TESARO, Inc., Waltham, MA, USA. · Xceleron, Inc., A Pharmaron Company, Germantown, MD, USA. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 29043410
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 30006796
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. · Division of Pharmacoepidemiology & Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 29429038
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. · Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28762135
2017
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital / The Netherlands Cancer Institute and MC Slotervaart, P.O. Box 90440, 1006 BK, Amsterdam, The Netherlands. · Tesaro Inc., Waltham, MA, USA. · Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital / The Netherlands Cancer Institute and MC Slotervaart, P.O. Box 90440, 1006 BK, Amsterdam, The Netherlands. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 28303528
2016
  • Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Clinical Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584CG, Utrecht, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27323902
  • Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Internal Medicine, Isala Clinics, Zwolle, the Netherlands. · Department of Internal Medicine, Antonius Hospital, Nieuwegein, the Netherlands. · Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands. · Department of Internal Medicine, Wilhelmina Hospital, Assen, the Netherlands. · Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, the Netherlands. · Department of Internal Medicine, Canisius Wilhemina Hospital, Nijmegen, the Netherlands. · Department of Internal Medicine, VieCuri Medical Center Noord-Limburg, Venlo, the Netherlands. · Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands. · Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands. · Department of Internal Medicine, Hospital de Tjongerschans, Heerenveen, the Netherlands. · Department of Cardiology, University Medical Center Groningen, the Netherlands. · Department of Laboratory Medicine University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands18Department of Pharmaceutical Sciences, Science Faculty Utrecht University, Utrecht, the Netherlands. · Pubmed 27348762
  • Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek/Slotervaart Hospital, Louwesweg 6, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek/Slotervaart Hospital, Louwesweg 6, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 26603889
2015
  • Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. Electronic address: · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Louwesweg 6, 1066EC Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, The Netherlands; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Louwesweg 6, 1066EC Amsterdam, The Netherlands. · Pubmed 26547132
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. Electronic address: · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 25997856
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Internal Medicine, Medisch Spectrum Twente, P.O. Box 50 000, 7500 KA, Enschede, The Netherlands. · Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences (UIPS), David de Wied building Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences (UIPS), David de Wied building Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Pubmed 26362459
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · 1] Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · 1] Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands. · Pubmed 26180927
  • Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Pubmed 26283654
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Programa de Farmacologia, Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · University of Helsinki, Helsinki, Finland. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Breakthrough Breast Cancer Centre, London, UK. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. · University of Helsinki, Helsinki, Finland. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. · Department of Pathology, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. · Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Jyväskylä Central Hospital, Jyväskylä, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Australia. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Cancer Epidemiology, Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Breakthrough Breast Cancer Centre, London, UK. · Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Pubmed 26137966
2017
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek and MC Slotervaart, Amsterdam; †Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; and ‡Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands. · Pubmed 28045782
2015
  • Science Faculty, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. · Pubmed 25413216
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam †Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam ‡Department of Pathology, University Medical Center Utrecht, Utrecht §Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam ¶Faculty of Science, Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. · Pubmed 26035041
2014
  • Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht University, Utrecht, The Netherlands, · Pubmed 24263964
2013
  • Science Faculty, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 24041361
2010
  • Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical Analysis, Division of Drug Toxicology, Utrecht, The Netherlands. · Pubmed 21137033
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 44 total) written by Jan H. M. Schellens about Breast Neoplasms:

  • PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer. 2018
  • Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer. 2018
  • Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides. 2018
  • Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study. 2018
  • Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a 2018
  • Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen. 2018
  • Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens. 2018
  • Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial. 2018
  • Human mass balance study and metabolite profiling of 2017
  • Fast and Adequate Liquid Chromatography-Tandem Mass Spectrometric Determination of Z-endoxifen Serum Levels for Therapeutic Drug Monitoring. 2017
Show List of Full Article Records
Google Searches

Learn more about Jan H. M. Schellens using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Leeuwenhoek Hospital
Universiteit Utrecht
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Leeuwenhoek Hospital
2018
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 29063517
  • Medical Oncology Department, Vall d'Hebrón University Hospital, Barcelona, Spain. · INCLIVA Biomedical Research Institute, Valencia, Spain. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Instituto Valenciano de Oncología, Valencia, Spain. · Medical University of South Carolina, Charleston, SC, USA. · Texas Oncology, Dallas, TX, USA. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · West German Cancer Center, University Hospital Essen, Essen, Germany. · Thomas Jefferson University, Philadelphia, PA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Manchester University, Manchester, UK. · Greenville Memorial Hospital, Greenville, SC, USA. · Novartis Pharma AG, Basel, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29882016
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg, 6, 1066, EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmaco-epidemiology & Clinical Pharmacology, Utrecht University, P.O. Box 80082, 3508, TB, Utrecht, The Netherlands. · Pubmed 29451684
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · TESARO, Inc., Waltham, MA, USA. · Xceleron, Inc., A Pharmaron Company, Germantown, MD, USA. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 29043410
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 30006796
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. · Division of Pharmacoepidemiology & Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 29429038
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. · Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28762135
2017
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital / The Netherlands Cancer Institute and MC Slotervaart, P.O. Box 90440, 1006 BK, Amsterdam, The Netherlands. · Tesaro Inc., Waltham, MA, USA. · Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital / The Netherlands Cancer Institute and MC Slotervaart, P.O. Box 90440, 1006 BK, Amsterdam, The Netherlands. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 28303528
2016
  • Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Clinical Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584CG, Utrecht, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27323902
  • Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Internal Medicine, Isala Clinics, Zwolle, the Netherlands. · Department of Internal Medicine, Antonius Hospital, Nieuwegein, the Netherlands. · Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands. · Department of Internal Medicine, Wilhelmina Hospital, Assen, the Netherlands. · Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, the Netherlands. · Department of Internal Medicine, Canisius Wilhemina Hospital, Nijmegen, the Netherlands. · Department of Internal Medicine, VieCuri Medical Center Noord-Limburg, Venlo, the Netherlands. · Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands. · Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands. · Department of Internal Medicine, Hospital de Tjongerschans, Heerenveen, the Netherlands. · Department of Cardiology, University Medical Center Groningen, the Netherlands. · Department of Laboratory Medicine University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands18Department of Pharmaceutical Sciences, Science Faculty Utrecht University, Utrecht, the Netherlands. · Pubmed 27348762
  • Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek/Slotervaart Hospital, Louwesweg 6, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek/Slotervaart Hospital, Louwesweg 6, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 26603889
2015
  • Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. Electronic address: · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Louwesweg 6, 1066EC Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, The Netherlands; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Louwesweg 6, 1066EC Amsterdam, The Netherlands. · Pubmed 26547132
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. Electronic address: · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 25997856
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Internal Medicine, Medisch Spectrum Twente, P.O. Box 50 000, 7500 KA, Enschede, The Netherlands. · Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences (UIPS), David de Wied building Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences (UIPS), David de Wied building Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Pubmed 26362459
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · 1] Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · 1] Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands. · Pubmed 26180927
  • Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Pubmed 26283654
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Programa de Farmacologia, Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · University of Helsinki, Helsinki, Finland. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Breakthrough Breast Cancer Centre, London, UK. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. · University of Helsinki, Helsinki, Finland. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. · Department of Pathology, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. · Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Jyväskylä Central Hospital, Jyväskylä, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Australia. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Cancer Epidemiology, Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Breakthrough Breast Cancer Centre, London, UK. · Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Pubmed 26137966
2014
  • Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 24219005
2018
  • Dejan Juric, Massachusetts General Hospital Cancer Center, Boston · Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · Jordi Rodon and Josep Tabernero, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona · Marta Gil-Martin, Catalan Institute of Oncology - Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain · Filip Janku, The University of Texas MD Anderson Cancer Center, Houston, TX · Howard A. Burris, Sarah Cannon Research Institute and Tennessee Oncology · Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN · Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam, the Netherlands · Mark R. Middleton, National Institute for Health Research, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom · Martin Schuler, West German Cancer Center, University Duisburg-Essen, and German Cancer Consortium, Partner Site University Hospital Essen, Essen · Ruth Seggewiss-Bernhardt, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Douglas Bootle, David Demanse, Lars Blumenstein, and Cornelia Quadt, Novartis Pharma AG, Basel, Switzerland · Christina Coughlin, Novartis Pharmaceuticals Corporation, East Hanover, NJ · and José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 29401002
2017
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek and MC Slotervaart, Amsterdam; †Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; and ‡Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands. · Pubmed 28045782
2015
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam †Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam ‡Department of Pathology, University Medical Center Utrecht, Utrecht §Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam ¶Faculty of Science, Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. · Pubmed 26035041
2014
  • European Medicines Agency, London, United Kingdom; Danish Health and Medicines Authority, København, Denmark; Department of Physiology and Pharmacology, Università di Roma "La Sapienza," Rome, Italy; Agenzia Italiana del Farmaco, Rome, Italy; Läkemedelsverket, Medical Products Agency, Uppsala, Sweden; Karolinska Institutet, Stockholm, Sweden; The Netherlands Cancer Institute, Amsterdam, The Netherlands · European Medicines Agency, London, United Kingdom; Danish Health and Medicines Authority, København, Denmark; Department of Physiology and Pharmacology, Università di Roma "La Sapienza," Rome, Italy; Agenzia Italiana del Farmaco, Rome, Italy; Läkemedelsverket, Medical Products Agency, Uppsala, Sweden; Karolinska Institutet, Stockholm, Sweden; The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 24928613
  • Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands, · Pubmed 24859000
  • Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands, · Pubmed 24390246
2013
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23053259
  • Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. · Pubmed 24373320
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 23645005
  • The Netherlands Cancer Institute, Division of Experimental Therapy, Amsterdam, The Netherlands. · Pubmed 23541706
2012
  • The Netherlands Cancer Institute, Department of Clinical Pharmacology, Postbus 90203, 1006 BE Amsterdam, The Netherlands. · Pubmed 22477724
  • Department of Clinical Pharmacology and Experimental Therapy, The Netherlands. · Pubmed 22264977
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22907417
2011
  • Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Pubmed 21392921
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Slotervaart Hospital, Amsterdam, The Netherlands. · Pubmed 21913038
  • The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Division of Clinical Pharmacology, Amsterdam, The Netherlands. · Pubmed 21911720
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 21633346
  • Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 21632460
  • Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21587256
2010
  • Department of Pharmacy & Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. · Pubmed 21094378
Universiteit Utrecht
2018
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 29063517
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg, 6, 1066, EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmaco-epidemiology & Clinical Pharmacology, Utrecht University, P.O. Box 80082, 3508, TB, Utrecht, The Netherlands. · Pubmed 29451684
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · TESARO, Inc., Waltham, MA, USA. · Xceleron, Inc., A Pharmaron Company, Germantown, MD, USA. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 29043410
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 30006796
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. · Division of Pharmacoepidemiology & Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 29429038
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. · Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28762135
2017
  • Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital / The Netherlands Cancer Institute and MC Slotervaart, P.O. Box 90440, 1006 BK, Amsterdam, The Netherlands. · Tesaro Inc., Waltham, MA, USA. · Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital / The Netherlands Cancer Institute and MC Slotervaart, P.O. Box 90440, 1006 BK, Amsterdam, The Netherlands. · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 28303528
2016
  • Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Clinical Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584CG, Utrecht, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27323902
  • Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Internal Medicine, Isala Clinics, Zwolle, the Netherlands. · Department of Internal Medicine, Antonius Hospital, Nieuwegein, the Netherlands. · Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands. · Department of Internal Medicine, Wilhelmina Hospital, Assen, the Netherlands. · Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, the Netherlands. · Department of Internal Medicine, Canisius Wilhemina Hospital, Nijmegen, the Netherlands. · Department of Internal Medicine, VieCuri Medical Center Noord-Limburg, Venlo, the Netherlands. · Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands. · Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands. · Department of Internal Medicine, Hospital de Tjongerschans, Heerenveen, the Netherlands. · Department of Cardiology, University Medical Center Groningen, the Netherlands. · Department of Laboratory Medicine University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands18Department of Pharmaceutical Sciences, Science Faculty Utrecht University, Utrecht, the Netherlands. · Pubmed 27348762
  • Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek/Slotervaart Hospital, Louwesweg 6, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek/Slotervaart Hospital, Louwesweg 6, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 26603889
2015
  • Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. Electronic address: · Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Louwesweg 6, 1066EC Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, The Netherlands; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Louwesweg 6, 1066EC Amsterdam, The Netherlands. · Pubmed 26547132
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. Electronic address: · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 25997856
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Internal Medicine, Medisch Spectrum Twente, P.O. Box 50 000, 7500 KA, Enschede, The Netherlands. · Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences (UIPS), David de Wied building Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Utrecht Institute of Pharmaceutical Sciences (UIPS), David de Wied building Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Pubmed 26362459
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · 1] Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · 1] Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands. · Pubmed 26180927
  • Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, David de Wied building, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. · Pubmed 26283654
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Programa de Farmacologia, Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · University of Helsinki, Helsinki, Finland. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Breakthrough Breast Cancer Centre, London, UK. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. · University of Helsinki, Helsinki, Finland. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · University of Helsinki, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. · Department of Pathology, University of Cambridge, Cambridge, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. · Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Jyväskylä Central Hospital, Jyväskylä, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Australia. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Cancer Epidemiology, Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Breakthrough Breast Cancer Centre, London, UK. · Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Pubmed 26137966
2017
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek and MC Slotervaart, Amsterdam; †Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht; and ‡Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands. · Pubmed 28045782
2015
  • Science Faculty, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. · Pubmed 25413216
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam †Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam ‡Department of Pathology, University Medical Center Utrecht, Utrecht §Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam ¶Faculty of Science, Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. · Pubmed 26035041
2014
  • Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht University, Utrecht, The Netherlands, · Pubmed 24263964
2013
  • Science Faculty, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Pubmed 24041361
2010
  • Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical Analysis, Division of Drug Toxicology, Utrecht, The Netherlands. · Pubmed 21137033
20 Other Locations Show
Yearly article counts 08238654620
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.